H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 17.24 HKD 0.7% Market Closed
Market Cap: 102.3B HKD
Have any thoughts about
Hansoh Pharmaceutical Group Company Ltd?
Write Note

Hansoh Pharmaceutical Group Company Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hansoh Pharmaceutical Group Company Ltd
Cost of Revenue Peer Comparison

Comparables:
600196
600436
600276
000538
S
688506

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cost of Revenue
-ÂĄ1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Cost of Revenue
-ÂĄ21.7B
CAGR 3-Years
-12%
CAGR 5-Years
-14%
CAGR 10-Years
-13%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cost of Revenue
-ÂĄ5.9B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cost of Revenue
-ÂĄ3.9B
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cost of Revenue
-ÂĄ28.7B
CAGR 3-Years
-3%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cost of Revenue
-ÂĄ242.3m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hansoh Pharmaceutical Group Company Ltd's Cost of Revenue?
Cost of Revenue
-1B CNY

Based on the financial report for Dec 31, 2023, Hansoh Pharmaceutical Group Company Ltd's Cost of Revenue amounts to -1B CNY.

What is Hansoh Pharmaceutical Group Company Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-11%

Over the last year, the Cost of Revenue growth was -19%. The average annual Cost of Revenue growth rates for Hansoh Pharmaceutical Group Company Ltd have been -9% over the past three years , -11% over the past five years .

Back to Top